37 results
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
growth, cell maturation, and cell death. Through mutations, the Ras proteins can be rendered persistently active, causing cancer cells to proliferate … disability and death benefits. Insured members may also buy into the scheme to improve their pension provision up to the maximum amount permitted under
F-1/A
EX-10.44
CYTO
Altamira Therapeutics Ltd
3 Jul 23
Registration statement (foreign) (amended)
7:09pm
the undersigned or members of the undersigned’s immediate family, (b) by will or intestate succession upon the death of the undersigned; (c) as a bona fide … are irrevocable and shall survive the death or incapacity of the undersigned (if a natural person) and shall be binding upon the heirs, personal
6-K
EX-99.2
CYTO
Altamira Therapeutics Ltd
24 Oct 22
Share Purchase Agreement
4:30pm
(for old age, disability, death, etc.) and to insurance schemes (for accidents, sickness, etc.) and all other taxes, social security contributions, duties
6-K
EX-99.1
bl51es5e hrcnhf
17 May 22
Report of Foreign Private Issuer
8:32am
424B3
djlw2wc220w83obvd
17 May 22
Prospectus supplement
8:30am
S-8
EX-99.1
aglt5lub 3v5exc
19 Jul 19
Registration of securities for employees
4:32pm
6-K
EX-1.1
wlhs5ojmk
16 May 19
Report of Foreign Private Issuer
7:26am
F-1/A
EX-1.1
hr7c28hds5d3o
10 May 19
Registration statement (foreign) (amended)
3:18pm
F-1/A
EX-1.1
shx4a 8g23trk
6 May 19
Registration statement (foreign) (amended)
5:26pm
424B3
imm43nai178q7llq
20 Feb 19
Prospectus supplement
5:01pm
424B3
kxffppw5lnv1r2
15 Feb 19
Prospectus supplement
4:31pm
F-1/A
96tcas59
13 Feb 19
Registration statement (foreign) (amended)
5:21pm
F-4/A
rk89f2q9
13 Feb 19
Registration of securities (foreign) (amended)
5:02pm